chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Swollen lymph nodes in the left inner arm pit/ swollen and non-painful lymph nodes on the left side the neck.; Painful lymph nodes in the left inner arm pit; This is a spontaneous report from a contactable other healthcare professional. A 27-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL0140), via an unspecified route of administration in left arm on 08Jan2021 (at the age of 27-years-old) and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL0140), via an unspecified route of administration in the right arm on 29Jan2021 at 13:00 (at the age of 27-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have any allergies to medications, food or other products. The patient did not receive any other medications in two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient received unspecified vaccine within four weeks of vaccination. On 11Jan2021, the patient experienced swollen and painful lymph nodes in the left inner arm pit and also swollen and non-painful lymph nodes on the left side of the neck. All occurred within the first few days after the first vaccination dose. Swollen lymph nodes had not reduced in size (nearing four months later), although pain was gone in a few days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On an unknown date, the patient underwent lab tests and procedures which included blood test (blood work) and the result was normal. The clinical outcome of the events, swollen and painful lymph nodes in the left inner arm pit and swollen and non-painful lymph nodes on the left side of the neck were unknown at the time of reporting.    No follow-up attempts are needed. No further information is expected.
Vaccine given at 3:14 pm, She fainted for 10 seconds then vomited twice. 3:18 pm Pulse: 60,  SPO2: 96,  3:20 pm BP 88/56 Left Arm, 3:21 pm BP 87/67 Right Arm
(Did not have a reaction from the vaccine, tested positive for COVID after receiving both vaccines and required hospitalization) Received Moderna COVID-19 vaccine on 2/4/21 (lot # 011M20A) and second dose on 3/4/21. Developed shortness of breath on 3/18/21, went to hospital and tested positive for COVID-19 on 3/22/21
Patient said he got dizzy within minutes of receiving vaccine and that resolved by 10 minutes after vaccine.  Around 10 minutes after vaccine patient said both his arms felt heavy and numb but he was able to move them and his fingers.  Patient had no other symptoms and walked out of pharmacy with his mother.
A 0.3 ml dose of an undiluted Pfizer vial was possibly administered to a patient.
Couldn't breath like someone put pillow on my face and I couldn't get air and woke me from a sound sleep and ended up not feeling; Couldn't breath like someone put pillow on my face and I couldn't get air and woke me from a sound sleep and ended up not feeling; This is a spontaneous report from a non-contactable consumer (patient).  A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot Number: ER8737) as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient reported, after the vaccine one, Pfizer 1st vaccination, 6 days later in evening of the first shot she awoke about 7 hours later after she went to sleep at night she could not breath like someone put a pillow on her face and she could not get air and it woke her from a sound sleep, 5 days later she ended up not feeling, meaning that was she had her symptom 5 days later and her husband got the shot same exact time ended up with a incapacitating bout of vertigo and she was calling to see if they had any other report of these kind (side effects). The outcome of both the events was unknown.  No follow-up attempts are possible. No further information is expected.
Information has been received from a health professional concerning a 40 year old female employee, with no history of shingles, who worked in a small area where close to 1000 doses of Zostavax (Oka/Merck) was administered to patients since August 2006.  It was confirmed that the patient was not vaccinated with Zostavax (Oka/Merck).  Subsequently the patient was diagnosed with shingles by her physician and treated.  No product quality complaint was involved.  No other information was provided.  This is one of several reports from the same source.  Additional information has been requested.
3 days after administration of Adacel pt was unable to move R shoulder, or rise from laying or sitting position w/o assistance. Discomfort in hips with weight bearing. Blurred vision, transient nausea, gait is stiff with marked discomfort somewhat relieved with Naprosyn. On exam decreased ROM to R UE decreased strength in R neck. Hyperreflexia to R UE and R LE.
16AUG91 Td given for nail injury; 17AUG91 states red, fevered & sore; 19AUG91 phoned clinic advise warm moist compress & APAP; 20AUG91 area 3" x 2.5" red fevered, c/o feeling bad; Advise warm compress & APAP; MD if needed;
This case was reported by a pharmacist via call center representative and described the occurrence of localized erythema in a 80-year-old male patient who received SHINGRIX (batch number X3M27, expiry date 29th August 2020). Concomitant products included Aspirin, finasteride, metoclopramide, Nitroglycerin, omeprazole, clonazepam, LOMOTIL and TOBRADEX. On 16th March 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On an unknown date, less than a month after receiving SHINGRIX, the patient experienced localized erythema and erythromacular rash. On an unknown date, less than a month after receiving SHINGRIX, the patient experienced localized erythema and erythromacular rash. On an unknown date, the outcome of the erythema and erythromacular rash were not recovered/not resolved. The reporter considered the localized erythema and erythromacular rash to be almost certainly related to SHINGRIX. Additional details were provided as follows: This case was previously not reported on the behalf of the patient. The patient received SHINGRIX in the left arm. After receiving SHINGRIX, the patient came into the pharmacy and reported that he had a 5 cm by 3 cm oval shape redness on his left temple. The healthcare professional reported that the patient came into the pharmacy the day before reporting (yesterday) and the healthcare professional saw the redness as well. The patient also reported that he had redness on the chest that he described as several red dots on his chest right underneath the chin.
h/a, rt arm hurting, sluggish, chills/sweats started late in day of shot & was full blown by next AM;
arm ballooned up the size of a small apple; arm turned bright red / got three dark red like something between a rash and blood blister; arm was burning hot to the touch; got three dark red like something between a rash and blood blister; got three dark red like something between a rash and blood blister; At the beginning it was light brown dots on her arm; This is a spontaneous report from a contactable consumer.This female consumer (patient) reported for herself that:  A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced arm ballooned up the size of a small apple, arm turned bright red / got three dark red like something between a rash and blood blister, arm was burning hot to the touch, got three dark red like something between a rash and blood blister, got three dark red like something between a rash and blood blister, at the beginning it was light brown dots on her arm. The clinical outcome of events were unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up
8:00 pm patient became fevered with temp of 101.5, complaints of parathesia in L arm with tingling radiating to L breast. L arm with swelling and redness at the site.
no adverse event; Adult Patient received 0.5 ml of pediatric vaccine instead of a bivalent Booster dose; This spontaneous case was reported by a nurse and describes the occurrence of INCORRECT DOSE ADMINISTERED (Adult Patient received 0.5 ml of pediatric vaccine instead of a bivalent Booster dose) and NO ADVERSE EVENT (no adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.   On 21-Sep-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 21-Sep-2022, the patient experienced INCORRECT DOSE ADMINISTERED (Adult Patient received 0.5 ml of pediatric vaccine instead of a bivalent Booster dose). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, INCORRECT DOSE ADMINISTERED (Adult Patient received 0.5 ml of pediatric vaccine instead of a bivalent Booster dose) and NO ADVERSE EVENT (no adverse event) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for INCORRECT DOSE ADMINISTERED (Adult Patient received 0.5 ml of pediatric vaccine instead of a bivalent Booster dose).    No concomitant medications were reported.   It was reported that, the vaccine administrator grabbed the underage Moderna 6 months to 5 years age vaccine and administered to the adult patient. This case contains information for the 1st of 5 Adult patient described by the reporter.  No treatment medications were reported.   This case was linked to US-MODERNATX, INC.-MOD-2022-650478, US-MODERNATX, INC.-MOD-2022-650483, US-MODERNATX, INC.-MOD-2022-650485 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-650483: US-MODERNATX, INC.-MOD-2022-650485:patient 3 US-MODERNATX, INC.-MOD-2022-650478:
3 yo boy with 4-5d fever, began soon after receiving influenza shot, no rash, fever now resolving - no h/o problems with flu shot prior to that.
Fever of 100.3 (normal temp is 97.5) Significant lethargy and tiredness.  Lack of appetite
14 year old received Janssen Covid 19 vaccine when current approval is only for 18 years and older.
Information has been received from a registered nurse referring to 7 unspecified patients of unknown age and gender. On unknown dates the patients each was vaccinated with a dose of improperly stored PROQUAD (Merck) (lot # K009892, expiry date: 11-JAN-2016, exposure on 10 F for 28.86 hours). The nurse confirmed that all doses of PROQUAD (Merck) were administered prior to its labeled expiration date and all vaccines had not been temperature excursion previously. No adverse events were reported. Additional information has been requested.
Caller states that she got her Vaccine at 2pm today.  Now with a tingling sensation on her lips and an increase in salivation.  Able to speak in long sentences.  Instructed to increase her fluid intake, use mints to her secretions and if it worsens or she notice any lip swelling or resp distress, to report to  the nearest ER.  RN
Rapidly progressive dementia, likely CJD. 01/02/07-records received and reviewed. DC DX for DOS 11/11-11/23/06 DX: rapidly progressive dementia, likely Creutzfeldt-Jakob disease. 30 minutes after receiving tetanus shot she reported roaring sensation in both ears, 2 weeks prior to admission she was evaluated and felt to have eustachian tube dysfunction. She had slowing mentation, blunted affect and confusion.  Allergist consults: rapid progressive dementia, although acute/chronic encephalopathy have been prescribed for a subset of vaccinations, not aware of this to be a result from Td vaccination. Per information received from the annual follow up she died Dec. 16th 2006. Follow-up: She died. Doctors did not admit that her affliction was triggered by a vaccine, but she developed symptoms 1/2 hr. after having the shot.
Fever documented at 102.7F, 2-3 hours, post vax. Received antipyretic.
Ten days after no initial reaction I developed a Red rash at injection site and swelling growing past the clinic doctors ink outline in a day, given an antibiotic for suspected skin infection. Next day the er doctor found rash looking like mine online and diagnosed it as an adverse reaction to covid vaccine and discontinued the antibiotics started day before saying there was no skin infection. The rash has faded by seven days later with no treatment and no other symptoms
Dizziness, Heart palpitations, heaviness and numbness of arms and legs, burning sensation in legs and back.
I had a large welt beginning 24 hours after my shot. My arm/muscle were nearly impossible to move and raise over my head. The diameter of the welt was approximately 3 inches across and circular in shape. The welt was red, raised and itchy. It lasted for 5 days and evolved into a bruise-like coloring of blue/purple, though it did not hurt to the touch like a bruise. The welt and coloring finally cleared after 7 days.
tingling down arm and into thumb; It's becoming debilitating; numbness down arm and into thumb; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling down arm and into thumb), ASTHENIA (It's becoming debilitating) and HYPOAESTHESIA (numbness down arm and into thumb) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (tingling down arm and into thumb), ASTHENIA (It's becoming debilitating) and HYPOAESTHESIA (numbness down arm and into thumb). At the time of the report, PARAESTHESIA (tingling down arm and into thumb), ASTHENIA (It's becoming debilitating) and HYPOAESTHESIA (numbness down arm and into thumb) outcome was unknown.            No treatment medication were provided. No concomitant medications were provided.
can't eat anything; "losing myself"/"inside pressure"; nausea; vomiting; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of FEEDING DISORDER (can't eat anything), FEELING ABNORMAL ("losing myself"/"inside pressure"), NAUSEA (nausea), VOMITING (vomiting) and PYREXIA (fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 26-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jun-2021, the patient experienced FEEDING DISORDER (can't eat anything), FEELING ABNORMAL ("losing myself"/"inside pressure"), NAUSEA (nausea), VOMITING (vomiting), PYREXIA (fever) and CHILLS (chills). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, FEEDING DISORDER (can't eat anything), FEELING ABNORMAL ("losing myself"/"inside pressure"), NAUSEA (nausea), VOMITING (vomiting), PYREXIA (fever) and CHILLS (chills) outcome was unknown.            The caller did not report his Age/DOB or concomitant medications.   The  patient used to drink a lot of water to feel better.
Dizzy, Very sore arm, Nausea, Fever, Achiness, Lethargy, Headache.
When the vaccine was administered the patient became pale, dizzy with loss of consciousness and involuntary movements.
Pt had COVID in January 2021 and was released from quarantine on 1/21/21. Patient has been short of breath since vaccine. Cannot pinpoint when it started. States he does have dementia which only effects his short term memory. He has been seen at the clinic and been given an inhaler to use. States his blood pressure has been elevated at times and O2 sats habe been in upper 90s but also dropped to upper 80s when short of breath. He had breathing test and an echocardiogram done
My arm is so sore after second shot, terribly sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (My arm is so sore after second shot, terribly sore) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced PAIN IN EXTREMITY (My arm is so sore after second shot, terribly sore). At the time of the report, PAIN IN EXTREMITY (My arm is so sore after second shot, terribly sore) outcome was unknown.            No concomitant medications reported by investigator No treatment medications provided by the reporter.
Mild fever, headache, tiredness within the next couple hours. Later on a lump in the throat, difficulty to breath, hypothermia.
SINCE EARLY MARCH,AFTER ENGERIX-B INJECTIONS ON 07-FEB-90 AND 11-APR-90, PT HAS BEEN EXPERIENCING MENORRHEA.  OB/GYN FEELS CONDITION COULD BE DUE TO ENGERIX-B.
Onset of runny nose, flushed skin, chunky cough and dry cough within 3 hours of receiving the vaccine. Symptoms continue today.
Roughly 4 mins after receiving vaccine, patient stated left arm (vaccinated arm) was numb and hand was "locked up", pt stated he could not move his left hand. Patient's vitals were taken and were ok (BP: 130/92 and HR: 72).  Patient waited for approximately 20 to 30 minutes and said he felt fine when he left. Patient was informed he should call PCP to tell them about the reaction ASAP to determine if he should go in for further testing.
Information has been received from a registered nurse and a medical record concerning a 19 year old white female patient with no family history of sudden death or syncope who on 27-AUG-2007 at 12:00 (also reported as 11:30), was vaccinated IM with a first dose of GARDASIL (Lot# 658222/0927U). Around 12:20, the patient became pale, sweaty, and felt short of breath. The patient used her albuterol inhaler and her symptoms got worse. The patient then went to the emergency room. It was reported that in the emergency room the patient felt weak. The patient had a normal exam and was afebrile. After an observation period, the patient developed bilateral axillary "LAD" and some anterior cervical "LAD" also. No neck pain, stiffness, headache, fever, signs of pyelo or other infection was reported. Patient now has left tonsillitis with exudate. She was diagnosed with acute pharyngitis. Pregnancy test was negative. A throat culture was taken and strep test results were not reported at this time. On arrival to the emergency room, the patient had "QTc" of 495 on electrocardiogram (ECG). The patient was treated with a dose of prednisolone and was improving, ambulating, stable and afebrile. On 27-AUG-2007, the patient recovered. Discharge medications were penicillin v potassium 500 mg, one tablet by mouth four times a day for 10 days and prednisolone 20 mg tablets, 3 by mouth every day for 2 days. The patient should recheck her ECG and follow up with her primary medical doctor. It was reported that the physician was unclear if the patient had symptom's of allergy from GARDASIL or pharyngitis. On 29-AUG-2007, the patient began YASMIN. Additional information is not expected.
Hot flashes; Loss of mobility lasting 36 hours; bone aches; fever; full chills; light headed and dizzy towards evening of that day; A spontaneous report (United States) was received from a consumer who was an 77-year-old, male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced chills, hot flashes, Loss of mobility lasting 36 hours, light headed and dizzy, bone aches and fever  The patient's medical history was not provided. The concomitant medications reported included tramadol, trazodone, zolpidem, hydroxyzine, gabapentin, tamsulosin, primidone, atorvastatin, montelukast, pantoprazole, fluoxetine, losartan, glipizide, clopidogrel, armodafinil, metformin and furosemide for unspecified indications.  On 11 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 012L20A) intramuscularly for prophylaxis of COVID-19 infection. On the same evening, the patient experienced, lightheaded and dizzy. The treatment for the events included paracetamol.  On 12 Jan 2021, the patient developed, chills, bone aches and fever. The treatment for the events included paracetamol.  On 17 Jan 2021, the patient reported experiencing hot flashes, chills and loss of mobility lasting 36 hours on an unknown date. No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not provided.  The outcome for the events, chills and hot flashes was unknown.  The events, bone aches and fever were considered resolved on 18 Jan 2021.  The events, loss of mobility lasting 36 hours, lightheaded and dizzy was considered resolved on an unknown date.
miscarriages; This is a spontaneous report from a Pfizer Sponsored Program. A contactable consumer (patient's friend) reporting same event under the same suspect product for four patients. This is one of four reports. A female patient of unspecified age received bnt162b2 (Pfizer covid vaccine), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported, Caller unwilling to complete the report) as dose number unknown, single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient was pregnant. The patient blamed her miscarriage on the vaccine. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101375474 same report/drug/AE, different patients;US-PFIZER INC-202101375755 same report/drug/AE, different patients;US-PFIZER INC-202101375754 same report/drug/AE, different patients
Injection site is itching, hard, and red in a one inch circle around it. Arm is extremely sore as well.